This is the question we are asked more than any other, and it is usually answered badly. The honest version is that UK law does not have a category called "research peptide". What it has is a definition of a medicinal product, and everything turns on whether a given product meets it. This page explains that definition, the two tests the regulator applies, and where laboratory reference materials sit in relation to them.
It is a factual reference, not legal advice. If you need a position you can rely on, take advice from a solicitor.
What the law actually regulates
The governing legislation is the Human Medicines Regulations 2012. Regulation 2(1) defines a medicinal product as:
(a) any substance or combination of substances presented as having properties of preventing or treating disease in human beings; or (b) any substance or combination of substances that may be used by or administered to human beings with a view to restoring, correcting or modifying a physiological function by exerting a pharmacological, immunological or metabolic action, or making a medical diagnosis.
Read it closely and you will notice the definition never mentions the substance itself. It is about what the product is presented as, and what it is used for. The same white powder can be a medicine in one context and not in another.
The two tests
Limb (a) is the presentation test. It asks how the product is held out to the person receiving it: the claims on the label, the packaging, the website copy, the marketing, and the implications a reasonable person would draw. A product that carries dosing instructions, before-and-after imagery, or any suggestion that it treats a condition is presented as a medicine, whatever the disclaimer at the bottom of the page says.
Limb (b) is the function test. It asks whether the product is supplied for administration to a person in order to change how their body works, by a pharmacological, immunological or metabolic mechanism.
The MHRA sets out how it applies both in Guidance Note 8, "A guide to what is a medicinal product", most recently revised in 2025. It weighs the claims made explicitly and implicitly, the properties of the active ingredient, the intended use, how the product is presented, and whether its primary mechanism is pharmacological, immunological or metabolic. Determinations are made case by case, product by product.
Why the distinction carries weight
Regulation 46 prohibits selling, supplying, or offering to sell or supply an unauthorised medicinal product in the UK. If a product meets the definition and has no marketing authorisation, supplying it is an offence. This is the obligation that sits on the supplier. Separately, Part 14 of the same Regulations restricts how medicines may be advertised, and advertising an unlicensed medicine is itself prohibited.
That is why the presentation test matters commercially as much as legally. A supplier who makes therapeutic claims about an unlicensed compound is not in a grey area. They have taken their own product across the line and described the offence themselves.
Where laboratory reference materials sit
A substance supplied as a reference material for in-vitro laboratory work, with no claims made about treating anything and no instructions for administering it to a person, does not engage the presentation test, and is not being supplied for the purpose the function test describes. On that basis it falls outside the medicines licensing regime.
Two qualifications are worth stating plainly. First, that position depends entirely on the product genuinely being presented and supplied that way; a disclaimer bolted onto a page that otherwise reads as a consumer health product will not save it. Second, the MHRA decides these questions case by case, and has acted against suppliers whose presentation it considered medicinal despite research-use wording.
Peptides of this kind are not controlled drugs. They are not scheduled under the Misuse of Drugs Act 1971, so the questions people often have in mind about possession do not arise. The regime that applies is the medicines regime, and it bites on supply and on advertising.
What this does not mean
It does not mean these products are approved, tested for safety in people, or suitable for human use. They are not licensed by the MHRA, they have not been through the assessment a licensed medicine goes through, and nothing about their legal classification as research material implies they are safe to take. A compound being lawfully supplied for laboratory work and a compound being safe to put in your body are entirely separate questions, and only one of them has been answered.
It also does not mean every supplier is equal. The legal position described here belongs to suppliers who actually operate this way. A site that publishes reconstitution calculators, dosing charts and human protocols is presenting a medicine, regardless of the footer.
How we operate
- Every product is supplied strictly as a laboratory reference material for in-vitro research use only.
- We make no medical, therapeutic or weight-loss claims anywhere on this site.
- We publish no dosing guidance, reconstitution calculators or administration instructions.
- Every product page and every physical label carries a research-use-only statement.
- The site carries an age check, and a research-use declaration is required at checkout.
- Purity and identity are verified per batch, and certificates of analysis are available on request.
Further reading: how purity and identity are verified, how to read a certificate of analysis, and our quality and testing reference.
Common questions
Is it illegal to buy research peptides in the UK?
The Human Medicines Regulations 2012 place their obligations on the person selling or supplying an unauthorised medicinal product, not on a private purchaser. The regulated act is supply, and advertising. Whether any particular product is a medicinal product at all depends on how it is presented and what it is supplied for, assessed case by case by the MHRA.
Do I need to be a registered researcher or an institution to order?
There is no register of research peptide buyers in the UK and no licence to hold. By ordering you confirm that you are 18 or over and that the material is for in-vitro laboratory research only, which is the basis on which it is sold.
Are these products approved by the MHRA?
No. They are not licensed medicines, they hold no marketing authorisation, and they have not been assessed by the MHRA for safety or efficacy in humans. They are laboratory reference materials.
Are research peptides controlled drugs?
No. The peptides listed on this site are not scheduled under the Misuse of Drugs Act 1971. The legislation that applies to them is the medicines regime, which regulates supply and advertising rather than possession.
Why do you not publish dosing information?
Because publishing it would present the product as something to be administered to a person, which is the test the MHRA applies to decide whether something is a medicine. Suppliers who publish dosing charts have answered that question against themselves.
Does a research-use-only disclaimer make anything legal?
On its own, no. The presentation test looks at the whole picture, including implied claims, imagery and the surrounding marketing. A disclaimer attached to a page that otherwise reads as a consumer health product does not change what the page is presenting.
Research use only. Every product referred to on this page is supplied as a laboratory reference material for in-vitro research. Not a medicine. Not licensed by the MHRA. Not for human or veterinary use, and not for ingestion, injection, topical application, diagnostic or therapeutic use.
